Fierce Pharma

OCTOBER 30, 2024

Ever since the FDA rejected zuranolone in major depressive disorder last year, brai | In the wake of a recent round of layoffs, the company this week revealed that it’s discontinuing a commercial medicine and giving up hopes for a pair of pipeline prospects.

Prospecting 214

Prospecting Medicine FDA 214

Fierce Pharma

SEPTEMBER 3, 2024

Semnur Pharmaceuticals, which is working on a non-opioid prospect for sciatica, has agreed to merge with special purpose acquisition company Denali Capital Acquisition Corp. Semnur Pharmaceuticals is following in its parent company Scilex's footsteps with a special purpose acquisition company (SPAC) merger.

Prospecting 214

Prospecting Pharmaceutical Specialization 214

World of DTC Marketing

JULY 22, 2021

The culture within pharma is driving people away, including new hires. Age discrimination within pharma is real. With the loss of more experienced people, the pharma industry is losing talent and gaining what? On Quora, there was a discussion about working within pharma s a recent MBA grad wanted the pros and cons.

Pharma 309

Pharma Marketing Ethics Patients 309

MedCity News

JULY 1, 2024

The post Eli Lilly Puts $1B on the Line to Expand its Cancer Radiopharmaceuticals Prospects appeared first on MedCity News. The clinical-stage startup, a Crinetics Pharmaceuticals spinout, develops radiopharmaceuticals that target GPCRs overexpressed by solid tumors.

Prospecting 190

Prospecting Pharmaceutical Biopharma Pharma 190

MedCity News

MAY 14, 2024

The post AbbVie Expands Psychiatric Drug Prospects, Inking R&D Pact With Neuroscience Startup appeared first on MedCity News. AbbVie’s alliance with Gilgamesh Pharmaceuticals is pursuing next-generation psychiatric medications.

Prospecting 176

Prospecting Side effects Pharmaceutical Medical 176

Fierce Pharma

JULY 5, 2023

Amneal Pharmaceuticals’ hopes for a midyear launch of its extended-release Parkinson’s disease prospect—and a shot at a potential $500 million peak sales opportunity in the U.S.—have

Prospecting 181

Prospecting Sales FDA Pharmaceutical 181

Fierce Pharma

JANUARY 8, 2024

Biopharma companies looking to maximize the visibility of their M&A activity often reveal deals during the J.P. Morgan Healthcare Conference. | In it’s annual Firepower report, EY says the biopharma industry enters 2024 with the capability and motivation to increase M&A activity.

Prospecting 224

Prospecting Biopharma Pharma Healthcare 224

MedCity News

OCTOBER 27, 2022

GSK drug otilimab failed a Phase 3 test in rheumatoid arthritis. Though the antibody drug met the main goal in two other pivotal studies, GSK said the limited efficacy in the third study means the company will not seek regulatory approval.

Prospecting 261

Prospecting Biopharma Pharma 261

MedCity News

SEPTEMBER 21, 2023

Seven months after Travere Therapeutics’ flagship drug received accelerated FDA approval in a rare kidney disease, the molecule has fallen short of the key goal of its confirmatory test. It’s the small molecule’s second Phase 3 failure this year.

Prospecting 293

Prospecting FDA Biopharma Pharma 293

World of DTC Marketing

MAY 17, 2022

Just 13% of people trust the pharma companies they interact with. If pharma is going to leap to a new era of marketing, they have to get to know their audiences. eMail marketing still provides a great ROI, but very few pharma companies use it because of complexities and privacy issues. The post A new era of pharma marketing?

Marketing 214

Marketing Pharma Prescription Prospecting 214

Fierce Pharma

NOVEMBER 17, 2022

After 2 rejections, FDA panel rallies around Ardelyx's kidney disease prospect. fkansteiner. Thu, 11/17/2022 - 06:51.

Prospecting 162

Prospecting FDA 162

Fierce Pharma

DECEMBER 1, 2022

Persistent Lexicon still working to get an audience with FDA on Type 1 diabetes prospect. Thu, 12/01/2022 - 07:06.

Prospecting 162

Prospecting FDA 162

Fierce Pharma

MAY 31, 2024

After Amgen’s KRAS confirmatory trial results were rejected by the FDA as uninterpretable, Bristol Myers Squibb has divulged details of its rival study. Bristol Myers Squibb has divulged the details of Krazati's confirmatory trial.

Prospecting 219

Prospecting FDA 219

Fierce Pharma

JUNE 17, 2024

The failure of Marinus Pharmaceuticals’ trial for ganaxolone as a treatment for persistent seizures has left the Philadelphia company facing the daunting prospect of conducting a new study to | The failure of Marinus Pharma’ trial for ganaxolone as a treatment for persisting seizures has left the Philadelphia company facing the daunting prospect of (..)

Prospecting 187

Prospecting Pharma Pharmaceutical 187

Fierce Pharma

DECEMBER 5, 2023

Travere Therapeutics will reduce its workforce by 20%, with the jo | Travere Therapeutics will reduce its workforce by 20%, with the job cuts focused on “non-field-based employees,” the company said on Tuesday.

Prospecting 242

Prospecting 242

Fierce Pharma

NOVEMBER 27, 2024

The results back up the confidence the CEOs have in their companies’ growth prospects. . | A survey of life sciences CEOs found that 94% plan to grow their workforce over the next three years, with 37% envisioning that the head count of their company will grow by at least 6%.

Biopharma 167

Biopharma Prospecting 167

MedCity News

NOVEMBER 22, 2023

With financing prospects dim and no one willing to take on its assets, Evelo is dissolving its business. Evelo Biosciences’ vision of using microbes to engage the gut and modulate immune responses remains unrealized.

Prospecting 306

Prospecting Biopharma Pharma 306

Fierce Pharma

MARCH 21, 2023

Despite CMS snub, Eisai is 'not so nervous' about Leqembi's long-term coverage prospects: US CEO fkansteiner Tue, 03/21/2023 - 09:41

Prospecting 130

Prospecting 130

MedCity News

APRIL 17, 2023

The deal comes as Merck looks for drug prospects that could make up for revenue declines facing blockbuster seller Keytruda, which faces patent expirations in coming years. Merck is acquiring Prometheus Biosciences and a lead drug candidate in development for inflammatory bowel disorders.

Medicine 287

Medicine Prospecting Leads Biopharma 287

Fierce Pharma

APRIL 22, 2024

The prospects for Vanda Pharmaceuticals’ 10-year-old circadian rhythm drug Hetlioz have grown that much dimmer after the U.S. | The prospects for Vanda Pharmaceuticals’ 10-year-old circadian rhythm drug Hetlioz have grown that much dimmer after the U.S.

Prospecting 222

Prospecting Pharmaceutical 222

Fierce Pharma

FEBRUARY 28, 2024

The first 12 months on the market for Apellis’ geographic atrophy (GA) drug Syfovre have been a roller-coaster ride. And there’s still more loops to negotiate. | The first 12 months on the market for Apellis’ geographic atrophy (GA) drug Syfovre have been a rollercoaster ride. And there are still more loops to negotiate.

Prospecting 182

Prospecting Marketing 182

Fierce Pharma

MAY 29, 2024

Neurocrine Biosciences’ dealmaking prospects may soon get another round of attention with the installment of a new CEO. | Neurocrine Biosciences' dealmaking prospects may get another round of attention with the installment of a new CEO.

Prospecting 213

Prospecting 213

MedCity News

JUNE 29, 2023

Eli Lilly is expanding its diabetes prospects by acquiring cell therapy developer Sigilon Therapeutics. The two companies are already partners in the development of a type 1 diabetes cell therapy currently in preclinical development.

Prospecting 254

Prospecting Biopharma Pharma 254

Fierce Pharma

OCTOBER 30, 2023

After Sarepta overcame several regulatory hurdles to finally win | After Sarepta overcame several regulatory hurdles to finally win FDA approval for its DMD gene therapy Elevidys, the company now faces the prospect of more FDA scrutiny because a pivotal study on the drug has failed on the primary endpoint.

Prospecting 259

Prospecting FDA 259

Fierce Pharma

OCTOBER 10, 2023

Now, as BlueRock Therapeutics advances its lead prospect, its parent company Bayer is ready to kick production into high gear. . | Despite the promise of cell therapies, manufacturing the personalized medicines at scale has been a limiting factor for many companies.

Prospecting 265

Prospecting Manufacturing Medicine Leads 265

Fierce Pharma

SEPTEMBER 20, 2024

Amid a parade of regulatory endorsements in Europe, Apellis Pharmaceuticals’ ophthalmology prospect pegcetacoplan has been left in the cold once again.

Prospecting 221

Prospecting Medicine Leads Pharmaceutical 221

European Pharmaceutical Review

NOVEMBER 3, 2022

Results from CPhI’s 2022 Pharma Index survey , announced at this year’s CPhI Frankfurt, showed pharma confidence in growth , innovation and manufacturing quality has reached record highs, promising positive prospects for the industry in 2023 and beyond. Key countries. Scores this year were the highest on record ( Figure 2 ).

Pharma 103

Pharma Manufacturing Competition Pharmaceutical products 103

Fierce Pharma

AUGUST 13, 2024

Despite winning an FDA approval in 2023 and gaining clarity in May on the regulatory path forward for its Type 1 diabetes prospect sotagliflozin, Lexicon Pharmaceuticals hasn’t had an easy go of it | As part of a restructuring initiative, Lexicon Pharmaceuticals will lay off more than 75 staffers, or approximately 50% of its current field force, by (..)

Prospecting 206

Prospecting FDA Pharmaceutical 206

Fierce Pharma

MAY 3, 2024

The buzz about Amgen’s obesity prospects overshadowed the company’s solid work on the top line as revenue came in at $7.4 During the Q&A portion of Amgen’s quarterly conference call Thursday, eight of the first nine questions were about the company’s investigational efforts in obesity. | billion for a 22% increase.

Prospecting 216

Prospecting Sales 216

Pharma Pathway

JANUARY 7, 2023

Sun Pharma- Walk-In Drive for QC/ Production On 8th Jan’ 2023 & Send Resumes for Engineering/ QA/ Warehouse. Walk-In Interview for Sun Pharma, Paonta Sahib On 8th Jan’ 2023. We are Hiring @ Sun Pharma, Paonta Sahib. Job Description. Department: QC/ Production. Experience: 02 to 10 years.

Engineering 98

Engineering Pharma Recruitment Prospecting 98

Pharma Pathway

DECEMBER 8, 2022

Sun Pharma-Walk-In Interviews for Multiple Openings in Production / Packing Operator On 11th Dec’ 2022. Walk-In Interviews for Production/ Packing Departments @ Sun Pharma. Venue: The Sun Pharma, Industrial Area-3, Dewas, M.P. Job Description. Department: Production Operator/ Packing Operator-Formulation.

Pharma 93

Pharma Recruitment Prospecting Education 93

World of DTC Marketing

JULY 30, 2021

Pharma companies, for the most part, still rely on outside digital agencies for their online work. Here are some of the things I learned in working with digital agencies at pharma. Prospective agencies should be asking you questions and listening, not pitching. Like anything, some agencies are better than others.

Media 286

Media Prescription Pharma Prospecting 286

Fierce Pharma

JUNE 26, 2024

Sanofi has told prospective buyers of its consumer health unit to provide bids for its consumer division by the middle of July, Bloomberg reports. It finally appears to be go-time in Sanofi’s continuing effort to separate from its consumer health unit.

Prospecting 195

Prospecting 195

pharmaphorum

JULY 28, 2024

The CHMP has backed LEO Pharma's delgocitinib for chronic hand eczema, considered to be one of its top pipeline prospects

Prospecting 114

Prospecting Pharma 114

Fierce Pharma

OCTOBER 30, 2023

The company entered an advance agreement for a priority review voucher ahead of the FDA's decision on the sickle cell disease gene therapy prospect. As an FDA decision draws closer on bluebird bio’s sickle cell disease gene therapy, the company has lined up a potential sale of a priority review voucher (PRV). |

FDA 219

FDA Prospecting Sales 219

Pharmaceutical Technology

JANUARY 10, 2023

AstraZeneca has signed a definitive agreement to buy US-based biopharmaceutical company CinCor Pharma in a deal valued at about $1.8bn. Under the deal, the company will initiate a tender offer to purchase all the outstanding shares of CinCor Pharma for $26 per share in cash.

Pharma 97

Pharma Prospecting Leads Patients 97

Pharmaceutical Representative Training

OCTOBER 9, 2024

Identifying and engaging the right prospects can make all the difference between success and stagnation, making it crucial to driving sales growth. 2 By honing in on the right prospects and understanding their needs, you can enhance their effectiveness and meet their sales goals more efficiently. So what is an ICP?

Prospecting 52

Prospecting Sales Pharmaceutical Sales Leads 52